Mycophenolic Acid

ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30198840 Pilot Conversion Study From Mycophenolate Mofetil to Everolimus in Stable ABO-Incompatible Kidney Transplant Recipients: Analysis of 1-Year Follow-Up Data. 2019 Apr 1
2 27534951 Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. 2017 Aug 1
3 27616538 Effect of hepatic drug transporter polymorphisms on the pharmacokinetics of mycophenolic acid in patients with severe renal dysfunction before renal transplantation. 2017 Oct 2
4 24329776 Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study. 2014 Jan 2
5 19820002 Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully with antigen-specific immunoadsorption. 2010 Jan 1
6 18622297 ABO incompatible renal transplantation in an HIV-seropositive patient. 2008 Jul 15 1
7 19100409 ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab. 2008 Dec 1
8 15973181 Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetil. 2005 Jun 27 1
9 15990643 Mycophenolate mofetil in the management of alloimmune hemolytic anemia in ABO-compatible but non-identical pediatric liver transplantation. 2005 Jul 1
10 16417450 Successful ABO-incompatible liver transplantation with pre- and postoperative plasmapheresis, triple immunosuppression, and splenectomy for fulminant hepatic failure. 2005 Dec 1
11 15518791 Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid. 2004 Sep 1
12 12698082 ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. 2003 Apr 15 1
13 12438969 Mycophenolate mofetil suppresses the production of anti-blood type anitbodies after renal transplantation across the abo blood barrier: ELISA to detect humoral activity. 2002 Oct 27 1
14 11328549 Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience. 2001 Apr 1
15 10915175 Acceptance of an ABO-incompatible mismatched (AB(+) to O(+)) liver allograft with the use of daclizumab and mycophenolate mofetil. 2000 Jul 2